Repare Therapeutics reports Q1 EPS 30c, consensus 2c
PremiumThe FlyRepare Therapeutics reports Q1 EPS 30c, consensus 2c
3M ago
Repare Therapeutics, Debiopharm dose first patient in Module 4 of MYTHIC trial
PremiumThe Fly
Repare Therapeutics, Debiopharm dose first patient in Module 4 of MYTHIC trial
3M ago
Repare Therapeutics Announces Board Changes and FD Disclosure
PremiumCompany Announcements
Repare Therapeutics Announces Board Changes and FD Disclosure
3M ago
RPTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsRPTX Upcoming Earnings Report: What to Expect?
5M ago
Repare Therapeutics doses first patient in LIONS clinical trial
PremiumThe Fly
Repare Therapeutics doses first patient in LIONS clinical trial
5M ago
Repare Therapeutics price target lowered to $10 from $25 at H.C. Wainwright
PremiumThe Fly
Repare Therapeutics price target lowered to $10 from $25 at H.C. Wainwright
5M ago
Capital One says buy these six biotech stocks for 2024
PremiumThe FlyCapital One says buy these six biotech stocks for 2024
6M ago
Capital One reveals top six biotech picks for 2024
PremiumThe Fly
Capital One reveals top six biotech picks for 2024
6M ago
Repare Therapeutics earns $40M milestone payment from Roche for TAPISTRY trial
PremiumThe Fly
Repare Therapeutics earns $40M milestone payment from Roche for TAPISTRY trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100